GPP
GOSS icon

Great Point Partners’s Gossamer Bio GOSS Stock Holding History

Great Point Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,230,272
Closed -$5.19M – 40
2023
Q3 		$5.19M Buy
+6,230,272
New +$7.18M 0.95% 30

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Great Point Partners's GOSS Position: Q4 2023 in Review

Great Point Partners sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 6,230,272 shares — an estimated $5.19M sold.

Great Point Partners first reported a position in GOSS in Q3 2023 and held it in 1 quarter. The position peaked at $5.19M in Q3 2023. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Great Point Partners reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Great Point Partners sold 6,230,272 Gossamer Bio shares in Q4 2023, an estimated $5.19M.
  • Great Point Partners first reported a position in Gossamer Bio in Q3 2023 and held it in 1 quarter.
  • Great Point Partners's Gossamer Bio position peaked at $5.19M in Q3 2023.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Great Point Partners's 13F filing for Q4 2023, filed 14 Feb 2024.